The BEAT AF study aims to make a difference in the management of atrial fibrillation. It involves 9 European clinical centres to prove that the pulse field ablation method, is more effective and safer than radiofrequency, the reference treatment to date. It will also reduce recurrences, which are still frequent. For more information.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement N° 945125
Project holder : Pierre Jais